Zinc formulations as a prophylactic treatment for the common cold
OwnerRichard A. Rosenbloom, Charles A. Phillipsinventors
Life of this patent
Estimating the term…
Abstract
Prophylactic treatment to reduce the incidence of common cold using formulations of zinc compounds with selected amino acids is described. The administration of such formulations to healthy individuals resulted in a statistically significant reduction in the incidence of common colds in healthy patients.
Claims12
A method for the reduction of the incidence of a common cold in a human comprising the step of administering to a human an effective amount of a composition containing a zinc compound and an amino acid to reduce the incidence of a common cold in a human, said amino acid being capable of forming a complex with said zinc compound, and said amino acid being selected from the group consisting of glycine, L-alanine, D,L-alanine, L-2-aminobutyric acid, D,L-2-aminobutyric acid, L-valine, D,L-valine, L-isovaline, D,L-isovaline, L-leucine, D,L-leucine, D-isoleucine, D,L-isoleucine, L-lysine, and D,L-lysine;
- said composition containing from about 1 mg to about 5 mg of zinc for each gram of said composition, and the molar ratio of said amino acid to zinc being from about 2 to 20.
Dependencies are inferred from the claim text.